145 related articles for article (PubMed ID: 3391527)
1. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
Denke MA; Grundy SM
Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
[No Abstract] [Full Text] [Related]
2. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Crouse JR
Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
[TBL] [Abstract][Full Text] [Related]
3. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
4. Bile acid sequestrants and hyperlipidaemia.
Lancet; 1988 Jan; 1(8579):220-1. PubMed ID: 2893044
[No Abstract] [Full Text] [Related]
5. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
6. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
[TBL] [Abstract][Full Text] [Related]
8. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
LaRosa J
Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
[TBL] [Abstract][Full Text] [Related]
9. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Harvengt C; Desager JP
Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
[TBL] [Abstract][Full Text] [Related]
10. Bile acid sequestrants.
Ast M; Frishman WH
J Clin Pharmacol; 1990 Feb; 30(2):99-106. PubMed ID: 2179278
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Day CE
Artery; 1990; 17(5):281-8. PubMed ID: 2396902
[TBL] [Abstract][Full Text] [Related]
12. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
Faruqui AM; Thurmond MS; Wenger J; Wenger NK
J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
[No Abstract] [Full Text] [Related]
14. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
Clifton-Bligh P; Miller NE; Nestel PJ
Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
[No Abstract] [Full Text] [Related]
15. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
16. Diet and drug treatment of hyperlipidemia and atherosclerosis.
Kuo PT
Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
[No Abstract] [Full Text] [Related]
17. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
18. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
19. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
